← Back to headlines



Ozempic's Canadian Patent Questioned as Generics Emerge
The Canadian patent for the weight loss drug Ozempic is being questioned as generic versions are reportedly set to enter the market.
22 May, 10:00 — 22 May, 10:00
Sources
Showing 1 of 1 sources
Related Stories

IMF Chief Warns Global Economy Faces Energy Shocks and Fiscal Pressures
18m ago

Abercrombie & Fitch Shares Surge on Strong Second-Quarter Earnings and Raised Guidance
34m ago

TWG Global Denies Fraud Allegations and Lakers Fire Sale Rumors Amid Federal Probe
38m ago

Montenegro Official Rejects Alleged Political Pressure Attempts
40m ago